Emina Džafo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emina Džafo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Francesco Gualdrini
IEO, European Institute of Oncology IRCCS 2 Department of Experimental Oncology Milan
2 shared publications - Silvia Monticelli
Institute for Research in Biomedicine, Università della Svizzera italiana 1 , Bellinzona
2 shared publications - Alessandro Cuomo
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS , Milan 20139
1 shared publication Amy Kenyon
Affiliation IEO, European Institute of Oncology IRCCS, Department of Experimental Oncology, Milan, Italy
1 shared publication- Amy Kenyon
IEO, European Institute of Oncology IRCCS 2 Department of Experimental Oncology Milan
1 shared publication - Bedin
IEO, European Institute of Oncology IRCCS 2 Department of Experimental Oncology Milan
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (12)
A genetically regulated SKAP2 switch modulates human T lymphocyte adhesion and migration
Genome-wide association studies investigating autoimmune disorders may reveal previously unrecognized regulators of immune cell functions. A Crohn’s disease risk allele was associated with increased expression in T lymphocytes of the adapter protein Src kinase–associated phosphoprotein 2 (SKAP2), whose functional role in these cells is unknown. By analyzing T cells from individuals homozygous for either allelic variant or engineered to modulate SKAP2 endogenous levels, we found that SKAP2 promotes T cell adhesion while restraining migration, acting nonredundantly with its homologue SKAP1. Consistent with such functional differences, SKAP1 and SKAP2 displayed distinct activation-induced regulation as well as unique protein interactomes. Prolonged TCR activation triggered caspase-mediated SKAP2 cleavage, leading to the disassembly of its interactome and enabling a migratory program. Together, these findings identify SKAP2 as a genetically regulated modulator of T cell function whose expression and activity control the balance between adhesion and migration.
- 20 October 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (12)
Open AccessA genetically regulated SKAP2 switch modulates human T lymphocyte adhesion and migration
Genome-wide association studies investigating autoimmune disorders may reveal previously unrecognized regulators of immune cell functions. A Crohn’s disease risk allele was associated with increased expression in T lymphocytes of the adapter protein Src kinase–associated phosphoprotein 2 (SKAP2), whose functional role in these cells is unknown. By analyzing T cells from individuals homozygous for either allelic variant or engineered to modulate SKAP2 endogenous levels, we found that SKAP2 promotes T cell adhesion while restraining migration, acting nonredundantly with its homologue SKAP1. Consistent with such functional differences, SKAP1 and SKAP2 displayed distinct activation-induced regulation as well as unique protein interactomes. Prolonged TCR activation triggered caspase-mediated SKAP2 cleavage, leading to the disassembly of its interactome and enabling a migratory program. Together, these findings identify SKAP2 as a genetically regulated modulator of T cell function whose expression and activity control the balance between adhesion and migration.
- Open Access
- 10 February 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (2) , e3001538
RFX transcription factors control a miR-150/PDAP1 axis that restrains the proliferation of human T cells
Within the immune system, microRNAs (miRNAs) exert key regulatory functions. However, what are the mRNA targets regulated by miRNAs and how miRNAs are transcriptionally regulated themselves remain for the most part unknown. We found that in primary human memory T helper lymphocytes, miR-150 was the most abundantly expressed miRNA, and its expression decreased drastically upon activation, suggesting regulatory roles. Constitutive MIR150 gene expression required the RFX family of transcription factors, and its activation-induced down-regulation was linked to their reduced expression. By performing miRNA pull-down and sequencing experiments, we identified PDGFA-associated protein 1 (PDAP1) as one main target of miR-150 in human T lymphocytes. PDAP1 acted as an RNA-binding protein (RBP), and its CRISPR/Cas-9–mediated deletion revealed that it prominently contributed to the regulation of T-cell proliferation. Overall, using an integrated approach involving quantitative analysis, unbiased genomics, and genome editing, we identified RFX factors, miR-150, and the PDAP1 RBP as the components of a regulatory axis that restrains proliferation of primary human T lymphocytes.
- 10 February 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (2) , e3001538
Open AccessRFX transcription factors control a miR-150/PDAP1 axis that restrains the proliferation of human T cells
Within the immune system, microRNAs (miRNAs) exert key regulatory functions. However, what are the mRNA targets regulated by miRNAs and how miRNAs are transcriptionally regulated themselves remain for the most part unknown. We found that in primary human memory T helper lymphocytes, miR-150 was the most abundantly expressed miRNA, and its expression decreased drastically upon activation, suggesting regulatory roles. Constitutive MIR150 gene expression required the RFX family of transcription factors, and its activation-induced down-regulation was linked to their reduced expression. By performing miRNA pull-down and sequencing experiments, we identified PDGFA-associated protein 1 (PDAP1) as one main target of miR-150 in human T lymphocytes. PDAP1 acted as an RNA-binding protein (RBP), and its CRISPR/Cas-9–mediated deletion revealed that it prominently contributed to the regulation of T-cell proliferation. Overall, using an integrated approach involving quantitative analysis, unbiased genomics, and genome editing, we identified RFX factors, miR-150, and the PDAP1 RBP as the components of a regulatory axis that restrains proliferation of primary human T lymphocytes.